GlucoTrack, Inc. (GCTK) vs IM Cannabis Corp. (IMCC)
A side-by-side comparison of GlucoTrack, Inc. and IM Cannabis Corp. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
GCTK
GlucoTrack, Inc.
$1.11HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT
IMCC
IM Cannabis Corp.
$1.94HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT
Total return — GCTK vs IMCC
growth of $100 · dividends reinvested · last 6yGCTK -100.0% (-87.7%/yr)IMCC -99.9% (-71.4%/yr)IMCC compounded faster over this window
Log scale — wide-divergence pair
GCTK IMCC
GCTK vs IMCC: by the numbers
- •IMCC is the larger company ($1M vs $885939 market cap).
- •Both run net losses; GCTK's is the smaller (0.00% vs -38.08% net margin).
Metrics side by side
Valuation
| Metric | GCTK | IMCC |
|---|---|---|
| P/S ratio | N/A | 0.04 |
Profitability
| Metric | GCTK | IMCC |
|---|---|---|
| Gross margin | 0.00% | 13.74% |
| Operating margin | 0.00% | -25.95% |
| Net margin | 0.00% | -38.08% |
| ROIC | N/A | -128.95% |
Growth (annualized)
| Metric | GCTK | IMCC |
|---|---|---|
| Revenue CAGR (5Y) | N/A | 4.19% |
| Total return CAGR (5Y) | -92.60% | -80.08% |
Frequently asked
- How have GCTK and IMCC total returns compared?
- Over the past 5 years, GCTK delivered -92.60% and IMCC delivered -80.08% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.